Regenerative Medical Technology Group Inc.
corporate_fare Company Profile
Regenerative Medical Technology Group Inc. (OTC:RMTG) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 6 items for RMTG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-19, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for RMTG spans 10-Q, PRE 14C, 10-K.
Recent high-impact activity:
- RMTG Q2 Revenue Soars 309% but Going Concern and Debt Defaults Persist
- Regenerative Medical Technology Group Seeks 4x Increase in Authorized Shares to Cover Massive Dilution Overhang
- Regenerative Medical Tech Reports 93.5% Revenue Surge to $2.64M, Losses Widen Amid Going Concern Warning
- Regenerative Medical Technology Group Reports Worsening Net Loss, Reiterates Going Concern Warning Amid Massive Debt Defaults
- RMTG Reports Widening FY25 Net Loss of $7.81M, EPS ($0.62), Despite Revenue Growth
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 175 shares in RMTG as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 100.0% of RMTG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for RMTG, detected from its recent SEC filings · based on capital-structure filings through 2026-08-17.
Authorized Shares Quadrupled · Massive Dilution Overhang
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →